Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 31.74
-0.998 %
$ 1.77 B
Market Cap
24.05
P/E
SUPN - STOCK-BASED COMPENSATION
Stock-based Compensation SUPN - Supernus Pharmaceuticals, Inc.
26.8 M
LAST VALUE
22.23%
2 YEAR CAGR
18.84%
5 YEAR CAGR
30.19%
10 YEAR CAGR